Xtant Medical Holdings (XTNT) Depreciation and Depletion (2011 - 2025)
Xtant Medical Holdings' (XTNT) quarterly Depreciation and Depletion came in at $700000.0 in Q3 2025, little changed year-on-year from $700000.0 in Q3 2024, and down 12.5% on a QoQ basis from $800000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) Depreciation and Depletion (2011 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 15 years of Depreciation and Depletion data on file, last reported at $700000.0 in Q3 2025.
- On a quarterly basis, Depreciation and Depletion changed 0.0% year-over-year to $700000.0 in Q3 2025; TTM through Sep 2025 was $2.8 million, a 16.67% increase from a year earlier, with the FY2024 full-year figure at $2.5 million, up 38.89% from the prior year.
- Depreciation and Depletion for Q3 2025 stood at $700000.0, down from $800000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for XTNT reached as high as $800000.0 in Q2 2025 and fell as low as $200000.0 in Q4 2022.
- Historically, Depreciation and Depletion has averaged $468421.1 across 5 years, with a median of $400000.0 in 2021.
- Across the five-year window, Depreciation and Depletion tumbled 42.86% in 2021 and surged 200.0% in 2023, its largest moves.
- Year by year, Depreciation and Depletion stood at $300000.0 in 2021, then plunged by 33.33% to $200000.0 in 2022, then jumped by 200.0% to $600000.0 in 2023, then advanced by 16.67% to $700000.0 in 2024, then changed by 0.0% to $700000.0 in 2025.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $700000.0 in Q3 2025, $800000.0 in Q2 2025, and $600000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | 78.00 Mn |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | - |
| 10 | Xtant Medical Holdings | 57.21 Mn | 39.88 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 700,000.00 |
| Sep 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 700,000.00 |
| Dec 31, 2024 | 700,000.00 |
| Sep 30, 2024 | 700,000.00 |
| Sep 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Dec 31, 2023 | 600,000.00 |
| Dec 31, 2023 | 600,000.00 |
| Sep 30, 2023 | 500,000.00 |
| Sep 30, 2023 | 500,000.00 |
| Jun 30, 2023 | 400,000.00 |
| Jun 30, 2023 | 400,000.00 |